9116 completed, 717 unknown, 422 recruiting, 340 terminated. 5835 Phase 1, 3259 Not applicable, 306 Phase 2, 285 Phase 4, 143 Early Phase 1.
Follow Healthy: new trials by email Literature Review of Healthy trials Research Report on Healthy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN Tetramethylpyrazine nitrone (TBN) tablet / Placebo - Healthy | Phase 1 | Not yet recruiting | Guangzhou Magpie Pharmaceuticals Co., Ltd. | 16 | 2028-09-01 | 2026-09-11 |
| Timed Aspirin Chronobiome Study Aspirin 81 mg, Celecoxib 200mg capsule - Healthy | Early Phase 1 | Not yet recruiting | University of Pennsylvania | 60 | 2027-12-01 | 2026-05-29 |
| EFFECTS OF DRAMA- AND ANİMATİON-SUPPORTED FİRST AİD EDUCATİON İN PRESCHOOL CHİLDREN Drama- and Animation-Supported First Aid Education (ÇİDA) Program - Healthy | Not applicable | Not yet recruiting | Kocaeli University | 50 | 2027-04-01 | 2026-10-02 |
| Reducing Pain-Related Sickness Absence Through Workplace Health Literacy: A Hybrid II Study Cognitive behavioural therapy-inspired digital education on pain and communication, Local work environment guidelines - Healthy, Musculoskeletal Disorders | Not applicable | Not yet recruiting | National Research Centre for the Working Environment, Denmark | 193 | 2027-03-01 | 2026-07-16 |
| Healthy Volunteer Recruitment and Characterization for NINDS Studies Healthy | Not yet recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 500 | 2027-02-08 | 2026-07-14 | |
| Research Investigating Drug Effects-2 (RiDE-2) Placebo Oral Capsule, THC - Cannabis Use, Substance Use Disorder (SUD) | Early Phase 1 | Not yet recruiting | University of Illinois at Chicago | 144 | 2027-01-04 | 2026-10-22 |
| A Phase 1, SAD and MAD to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral FB-101 in Healthy Adult Male Subjects FB-101, Placebo for FB-101 - Healthy | Phase 1 | Not yet recruiting | 1ST Biotherapeutics, Inc. | 72 | 2027-01-01 | 2026-09-02 |
| Pulse Revolution: Enhancing Metabolic Health Through the Power of Processed Chickpeas Control, Whole Chickpeas, Puréed Chickpeas - Healthy | Not applicable | Not yet recruiting | USDA Grand Forks Human Nutrition Research Center | 204 | 2027-01-01 | 2026-10-13 |
| Pomegranate Dietary Supplements in AUD and ALD Pomegranate Dietary Ssupplement - Alcohol Use Disorder, Alcohol-associated Liver Disease | Not yet recruiting | University of Louisville | 144 | 2027-01-01 | 2026-07-24 | |
| Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation? Time of OPU - Healthy | Not yet recruiting | ART Fertility Clinics LLC | 20 | 2026-12-30 | 2026-05-07 | |
| Hyperthermia in Patients With Chronic Primary Pain - Effects on Thermoregulation, Somatosensory System and Movement Evoked Pain serial whole body hyperthermia - Hyperthermia, Chronic Primary Pain | Not applicable | Not yet recruiting | Bern University of Applied Sciences | 60 | 2026-12-01 | 2026-09-30 |
| Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection. A. Ceftriaxone (Roche ®) 500mg (slow intravenous injection), B. Ceftriaxone rectal dosage form test formulation 1 (1 x 500mg), C. Ceftriaxone rectal dosage form test formulation 2 (1 x 500mg) - Healthy | Phase 1 | Suspended | University of Oxford | 37 | 2026-12-01 | 2025-12-26 |
| A Clinical Trial of MK-6916 With Midazolam and Rosuvastatin in Healthy Participants (MK-6916-012) Midazolam, Rosuvastatin, MK-6916 - Healthy | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 18 | 2026-11-30 | 2026-10-07 |
| Meditation and Yogic Breathing-driven Modulation of Neurofluid Coupling and Brain Clearance Nadi Shuddhi, Shoonya Meditation - Healthy | Not applicable | Not yet recruiting | Beth Israel Deaconess Medical Center | 120 | 2026-11-16 | 2026-10-29 |
| PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) 18F-PF974, 18F-florbetaben - Alzheimer s Disease, Mild Cognitive Impairment | Phase 1 | Recruiting | National Institute of Mental Health (NIMH) | 90 | 2026-11-04 | 2026-10-30 |
| First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE4D Imaging in Healthy Volunteers [11C]JMJ-129-d2 - Healthy | Phase 1 | Recruiting | National Institute of Mental Health (NIMH) | 40 | 2026-11-04 | 2026-10-30 |
| Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers Healthy | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 120 | 2026-11-04 | 2026-10-30 | |
| A Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy People BI 3821001, Placebo - Healthy | Phase 1 | Not yet recruiting | Boehringer Ingelheim | 40 | 2026-11-03 | 2026-10-30 |
| Timing of Subcutaneous Tranexamic Acid Injection in Mohs Micrographic Surgery Subcutaneous TXA injection before reconstruction, Subcutaneous TXA injection after reconstruction - Healthy | Not applicable | Not yet recruiting | The Cooper Health System | 500 | 2026-11-01 | 2026-09-08 |
| Essential Oil-Based Product System for Digestive Support essential oil supplement, Essential Oil, Placebo supplement - Healthy | Not applicable | Not yet recruiting | dōTERRA International | 40 | 2026-11-01 | 2026-06-17 |
Showing 20 of 11133. Sign in to see all of them.
Motor Activity (176) · Diabetes Mellitus (141) · Obesity (139) · Diabetes Mellitus, Type 2 (82) · Overweight (79) · Inflammation (66) · Alzheimer Disease (56) · Pain (55) · Stroke (53) · Insulin Resistance (52) · Depression (48) · Asthma (43) · Cognitive Dysfunction (42) · Influenza, Human (40) · Anxiety Disorders (38)
Pathological Conditions, Signs and Symptoms (788) · Nutritional and Metabolic Diseases (519) · Signs and Symptoms (510) · Behavior (418) · Nervous System Diseases (379) · Metabolic Diseases (374) · Mental Disorders (300) · Glucose Metabolism Disorders (283) · Pathologic Processes (282) · Endocrine System Diseases (273) · Respiratory Tract Diseases (252) · Central Nervous System Diseases (227) · Infections (227) · Neurologic Manifestations (225) · Brain Diseases (208)
Metformin (121) · Midazolam (105) · Moxifloxacin (100) · Tablets (99) · Itraconazole (91) · Exercise (82) · Rosuvastatin Calcium (76) · Sodium Chloride (75) · Omeprazole (64) · Ritonavir (58) · Rifampin (48) · Dabigatran (45) · Digoxin (44) · Caffeine (42) · Linagliptin (42)
Boehringer Ingelheim (812) · Pfizer (379) · Eli Lilly and Company (290) · Janssen Research & Development, LLC (232) · Teva Pharmaceuticals USA (161) · Dr. Reddy's Laboratories Limited (156) · AstraZeneca (152) · Mylan Pharmaceuticals Inc (149) · Novo Nordisk A/S (127) · Merck Sharp & Dohme LLC (116) · Ranbaxy Laboratories Limited (100) · National Institute of Neurological Disorders and Stroke (NINDS) (94) · Mayo Clinic (85) · Actavis Inc. (67) · University of Electronic Science and Technology of China (67)
United States (3979) · Germany (635) · United Kingdom (572) · Canada (470) · Belgium (465) · South Korea (440) · China (437) · France (301) · Netherlands (225) · Switzerland (224) · Japan (208) · India (197) · Denmark (196) · Turkey (Türkiye) (188) · Spain (161)
James D Carlson, Pharm. D. (51) · Dorian Williams, M.D. (42) · Ahmed Elshafeey, Ph.D. Pharma (34)
PMID 33128208, PMID 25078976, PMID 36451029, PMID 39175217, PMID 20844485, PMID 24868146, PMID 25078977, PMID 29856004, PMID 32348036, PMID 33969456, PMID 34473343, PMID 35061234, PMID 40455255, PMID 23497760, PMID 24408516, PMID 25345427, PMID 27140803, PMID 29912955, PMID 30908082, PMID 31889148, PMID 33654425, PMID 35344588, PMID 36919398, PMID 37917289, PMID 37929831, PMID 38054726, PMID 38267790, PMID 40117091, PMID 42563128, PMID 42684025, PMID 10454950, PMID 11558991, PMID 1490793, PMID 15208005, PMID 16527396, PMID 17898520, PMID 17899675, PMID 18832427, PMID 20126394, PMID 20573794, PMID 20817711, PMID 21150884, PMID 21480191, PMID 21804667, PMID 22104544, PMID 22323576, PMID 22408210, PMID 22883447, PMID 23564997, PMID 23756334
2014 (76), 2018 (73), 2015 (72), 2017 (70), 2019 (70), 2016 (54), 2023 (48), 2009 (34), 2025 (25), 2008 (16), 2005 (9), R01DC011287 (4), 2004 (3), R01DK126206 (3), R01ES033743 (3)